Reply to: “Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed”

Saved in:
Bibliographic Details
Published in:Hepatology international 2024-10, Vol.18 (5), p.1589-1590
Main Authors: Zeng, Zhen-Xin, Wu, Jia-Yi, Zhuang, Shao-Wu, Yan, Mao-Lin
Format: Article
Language:English
Subjects:
Carcinoma, Hepatocellular - drug therapy
Carcinoma, Hepatocellular - therapy
Chemoembolization, Therapeutic - methods
Colorectal Surgery
Hepatocellular carcinoma
Hepatology
Humans
Immune Checkpoint Inhibitors - therapeutic use
Letter to the Editor
Liver Neoplasms - drug therapy
Liver Neoplasms - pathology
Liver Neoplasms - therapy
Medicine
Medicine & Public Health
Phenylurea Compounds - therapeutic use
Prognosis
Quinolines - therapeutic use
Surgery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1936-0533
1936-0541
1936-0541
DOI:10.1007/s12072-024-10682-6